Form 8-K - Current report:
SEC Accession No. 0001520138-22-000448
Filing Date
2022-10-05
Accepted
2022-10-04 21:58:50
Documents
15
Period of Report
2022-10-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bivi-20221004_8k.htm   iXBRL 8-K 31021
2 EX-99.1 bivi-20221004_8kex99z1.htm EX-99.1 49149
7 GRAPHIC ex99-1_1.jpg GRAPHIC 81966
8 GRAPHIC ex99-1_2.jpg GRAPHIC 33613
  Complete submission text file 0001520138-22-000448.txt   423681

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE bivi-20221004.xsd EX-101.SCH 3239
5 XBRL LABEL FILE bivi-20221004_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE bivi-20221004_pre.xml EX-101.PRE 22367
10 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20221004_8k_htm.xml XML 3599
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39015 | Film No.: 221294407
SIC: 2834 Pharmaceutical Preparations